Biosign Announces Business Development Agreement



    TORONTO, July 10 /CNW/ - Biosign Technologies Inc. (the "Company",
"Biosign") (CNQ: BIOS) announced today that it has engaged Avro Capital Corp.
to assist with business development.
    Avro will provide the Company a full range of business development
services, including sales, marketing, and corporate finance. Corporate finance
services include assisting the Company in securing equity financing on the
order of two million dollars and an optional, mid-term financing of up to ten
million dollars.
    The term of the Agreement is twelve months, starting July 9, 2008.
    %SEDAR: 00014068E




For further information:

For further information: Radu Leca, President & CEO, Biosign
Technologies Inc., Phone: (416) 218-9800 ext. 222, Email: ceo@biosign.com

Organization Profile

Biosign Technologies Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890